These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1953964)

  • 21. Acute nicotine administration in Alzheimer's disease: an exploratory EEG study.
    Knott V; Engeland C; Mohr E; Mahoney C; Ilivitsky V
    Neuropsychobiology; 2000; 41(4):210-20. PubMed ID: 10828731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrahydroaminoacridine and lecithin in the treatment of Alzheimer's disease. Effect on cognition, functioning in daily life, behavioural disturbances and burden experienced by the carers.
    Weinstein HC; Teunisse S; van Gool WA
    J Neurol; 1991 Feb; 238(1):34-8. PubMed ID: 2030370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities.
    Nordberg A; Amberla K; Shigeta M; Lundqvist H; Viitanen M; Hellström-Lindahl E; Johansson M; Andersson J; Hartvig P; Lilja A; Långström B; Winblad B
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):228-37. PubMed ID: 9772028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of stimulant medications on the EEG of girls with Attention-Deficit/Hyperactivity Disorder.
    Clarke AR; Barry RJ; McCarthy R; Selikowitz M; Johnstone SJ
    Clin Neurophysiol; 2007 Dec; 118(12):2700-8. PubMed ID: 17911040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
    Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
    Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment with tacrine (THA) in Alzheimer's disease--evaluation of neuropsychological data.
    Amberla K; Nordberg A; Viitanen M; Winblad B
    Acta Neurol Scand Suppl; 1993; 149():55-7. PubMed ID: 8128841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-Hz wide EEG bands in Alzheimer's disease.
    Martin-Loeches M; Gil P; Rubia FJ
    Biol Psychiatry; 1993 Feb; 33(3):153-9. PubMed ID: 8448263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of THA on scopolamine and nucleus basalis lesion-induced EEG slowing.
    Riekkinen P; Jäkälä P; Sirviö J; Koivisto E; Miettinen R; Riekkinen P
    Brain Res Bull; 1991 Apr; 26(4):633-7. PubMed ID: 1868362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrine in Alzheimer's disease.
    Eagger SA; Levy R; Sahakian BJ
    Lancet; 1991 Apr; 337(8748):989-92. PubMed ID: 1673209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study.
    Moraes Wdos S; Poyares DR; Guilleminault C; Ramos LR; Bertolucci PH; Tufik S
    Sleep; 2006 Feb; 29(2):199-205. PubMed ID: 16494088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial.
    Maltby N; Broe GA; Creasey H; Jorm AF; Christensen H; Brooks WS
    BMJ; 1994 Apr; 308(6933):879-83. PubMed ID: 8173365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Brain mapping for discriminating age related changes from dementia].
    Szelies B
    Nervenarzt; 1992 Oct; 63(10):609-18. PubMed ID: 1436251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EEG filtering based on blind source separation (BSS) for early detection of Alzheimer's disease.
    Cichocki A; Shishkin SL; Musha T; Leonowicz Z; Asada T; Kurachi T
    Clin Neurophysiol; 2005 Mar; 116(3):729-37. PubMed ID: 15721088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic usefulness of linear and nonlinear quantitative EEG analysis in Alzheimer's disease.
    Stam CJ; Jelles B; Achtereekte HA; van Birgelen JH; Slaets JP
    Clin Electroencephalogr; 1996 Apr; 27(2):69-77. PubMed ID: 8681465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative EEG mapping, regional cerebral blood flow, and neuropsychological function in Alzheimer's disease.
    Passero S; Rocchi R; Vatti G; Burgalassi L; Battistini N
    Dementia; 1995; 6(3):148-56. PubMed ID: 7620527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
    Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM
    N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures.
    Salinsky MC; Oken BS; Storzbach D; Dodrill CB
    Epilepsia; 2003 Aug; 44(8):1042-50. PubMed ID: 12887435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of tetrahydroaminoacridine (THA) on P300 in Alzheimer's disease.
    van Gool WA; Waardenburg J; Meyjes FE; Weinstein HC; de Wilde A
    Biol Psychiatry; 1991 Nov; 30(9):953-7. PubMed ID: 1747439
    [No Abstract]   [Full Text] [Related]  

  • 39. Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease.
    Alhainen K; Partanen J; Reinikainen K; Laulumaa V; Soininen H; Airaksinen M; Riekkinen P
    Neurosci Lett; 1991 Jun; 127(1):113-6. PubMed ID: 1881606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease and THA: a review of the cholinergic theory and of preliminary results.
    Boller F; Forette F
    Biomed Pharmacother; 1989; 43(7):487-91. PubMed ID: 2684292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.